nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers
|
Ragupathi, Govind |
|
2003 |
52 |
10 |
p. 608-616 |
artikel |
2 |
Development of Therapeutic Cancer Vaccines Conference, 27–29 April 2003
|
Marshall, Margaret |
|
2003 |
52 |
10 |
p. 648-654 |
artikel |
3 |
Development of Therapeutic Cancer Vaccines Conference, 27–29 April 2003
|
Marshall, Margaret |
|
|
52 |
10 |
p. 648-654 |
artikel |
4 |
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients
|
Durrant, L. G. |
|
2003 |
52 |
10 |
p. 638-642 |
artikel |
5 |
Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells
|
Sanz, Laura |
|
2003 |
52 |
10 |
p. 643-647 |
artikel |
6 |
Lymphocyte subsets and Th1/Th2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome
|
Sandick, Johanna W. van |
|
2003 |
52 |
10 |
p. 617-624 |
artikel |
7 |
Optimizing dendritic cell–based anticancer immunotherapy: maturation state does have clinical impact
|
McIlroy, Dorian |
|
2003 |
52 |
10 |
p. 583-591 |
artikel |
8 |
Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer
|
Tsukishiro, Takashi |
|
2003 |
52 |
10 |
p. 599-607 |
artikel |
9 |
Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay
|
Mitchell, Malcolm S. |
|
|
52 |
10 |
p. 655-660 |
artikel |
10 |
Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay
|
Mitchell, Malcolm S. |
|
2003 |
52 |
10 |
p. 655-660 |
artikel |
11 |
The effects of αGalCer-induced TCRVα24 Vβ11+ natural killer T cells on NK cell cytotoxicity in umbilical cord blood
|
Ueda, Yoko |
|
2003 |
52 |
10 |
p. 625-631 |
artikel |
12 |
Tumor immunotherapy by converting tumor cells to MHC class II–positive, Ii protein–negative phenotype
|
Lu, Xueqing |
|
2003 |
52 |
10 |
p. 592-598 |
artikel |
13 |
Tumor mRNA–loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma
|
Kobayashi, Tsutomu |
|
2003 |
52 |
10 |
p. 632-637 |
artikel |